Evolve HealthCare Partners partners with Cera Care to accelerate continued growth 

Evolve HealthCare Partners, (“Evolve”), the European mid-market specialist investor in healthcare, together with the existing institutional shareholders, have led a capital injection in Cera Care (“Cera” or the “Company”) to support and accelerate its continuous growth. 

Evolve has co-invested alongside Schroder Adveq. 


Healthcare Private Equity: 
Investing in a POST-COVID World

The global Covid-19 crisis will lead to unprecedented change.  

Certain healthcare sectors will be re-defined as strategic infrastructure and new trends will emerge that will persist beyond the crisis.  

We examine the five key post-Covid-19 trends and the likely investment opportunities that will arise.


Novel approaches to value creation in healthcare private equity

Evolve Healthcare Partners featured in the Laing &  Buisson Private Equity in Healthcare Market Report 4ed

In addition to traditional levers, a more pragmatic and hands on approach is required to unlock the full potential of healthcare private equity investments

December 2019

© 2019 

All Rights Reserved